NASDAQ:EDAP - Edap Tms Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$3.20 -0.06 (-1.84 %)
(As of 06/18/2018 06:00 AM ET)
Previous Close$3.20
Today's Range$3.15 - $3.2833
52-Week Range$2.07 - $4.25
Volume255,627 shs
Average Volume1.95 million shs
Market Capitalization$92.79 million
P/E RatioN/A
Dividend YieldN/A
Beta0.74

About Edap Tms (NASDAQ:EDAP)

Edap Tms logoEDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. It offers Ablatherm, a HIFU device for the treatment of organ-confined prostate cancer, referred to as T1-T2 stage; and Focal One device, a HIFU robotic device for the focal therapy of localized prostate cancer. This division also leases equipment; sells disposables and spare parts; and offers maintenance services. The UDS division develops, manufactures, markets, and services medical devices for the minimally invasive diagnosis or treatment of urological disorders primarily urinary stones and other clinical indications. It offers lithotripters, such as Sonolith i-move and Sonolith i-sys for the treatment of urinary tract stones by means of extracorporeal shockwave lithotripsy technology. This division also leases lithotripters; sells disposables and spare parts; and provides maintenance services. The company markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. Its customers include public and private hospitals, urology clinics, and research institutions. The company was founded in 1979 and is based in Vaulx-en-Velin, France.

Receive EDAP News and Ratings via Email

Sign-up to receive the latest news and ratings for EDAP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:EDAP
CUSIPN/A
Phone33-04-72-15-31-50

Debt

Debt-to-Equity Ratio0.05
Current Ratio2.45
Quick Ratio2.04

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$40.74 million
Price / Sales2.28
Cash Flow$0.0455 per share
Price / Cash70.35
Book Value$0.98 per share
Price / Book3.27

Profitability

EPS (Most Recent Fiscal Year)($0.01)
Net Income$-760,000.00
Net Margins-5.98%
Return on Equity-5.89%
Return on Assets-3.22%

Miscellaneous

Employees197
Outstanding Shares29,000,000

Edap Tms (NASDAQ:EDAP) Frequently Asked Questions

What is Edap Tms' stock symbol?

Edap Tms trades on the NASDAQ under the ticker symbol "EDAP."

How were Edap Tms' earnings last quarter?

Edap Tms SA (NASDAQ:EDAP) announced its quarterly earnings data on Monday, May, 14th. The medical equipment provider reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.02) by $0.05. The medical equipment provider had revenue of $11.28 million for the quarter, compared to the consensus estimate of $10.46 million. Edap Tms had a negative net margin of 5.98% and a negative return on equity of 5.89%. View Edap Tms' Earnings History.

When is Edap Tms' next earnings date?

Edap Tms is scheduled to release their next quarterly earnings announcement on Wednesday, August, 22nd 2018. View Earnings Estimates for Edap Tms.

What price target have analysts set for EDAP?

1 brokers have issued 12 month price targets for Edap Tms' stock. Their predictions range from $6.50 to $6.50. On average, they expect Edap Tms' stock price to reach $6.50 in the next twelve months. View Analyst Ratings for Edap Tms.

What are Wall Street analysts saying about Edap Tms stock?

Here are some recent quotes from research analysts about Edap Tms stock:
  • 1. HC Wainwright analysts commented, "We have adjusted our financial model to reflect the reported 1Q18 financial results. For 2018, we project revenues of approximately €39.0M and a net loss of €0.01 per share. The company reported €18.1M in cash, cash equivalents and short- term investments as of March 31, which we believe is sufficient to fund operations for the foreseeable future." (5/16/2018)
  • 2. According to Zacks Investment Research, "EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors. " (4/10/2018)

Who are some of Edap Tms' key competitors?

Who are Edap Tms' key executives?

Edap Tms' management team includes the folowing people:
  • Mr. Marc Oczachowski, CEO & Director (Age 48)
  • Mr. Franois Dietsch, Chief Financial Officer (Age 42)
  • Mrs. Blandine Confort, Investor Relations Officer and Sec.
  • Ms. Judith Johannsen, Sales Director for Germany Austria & Switzerland and Gen. Mang. of Edap Gmbh
  • Mr. John Cameron Rewcastle, VP of Strategic Devel. (Age 44)

Has Edap Tms been receiving favorable news coverage?

Media coverage about EDAP stock has trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Edap Tms earned a media sentiment score of 0.15 on Accern's scale. They also gave news articles about the medical equipment provider an impact score of 46.31 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Who are Edap Tms' major shareholders?

Edap Tms' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Archon Capital Management LLC (3.51%). View Institutional Ownership Trends for Edap Tms.

Which institutional investors are buying Edap Tms stock?

EDAP stock was bought by a variety of institutional investors in the last quarter, including Archon Capital Management LLC. View Insider Buying and Selling for Edap Tms.

How do I buy shares of Edap Tms?

Shares of EDAP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Edap Tms' stock price today?

One share of EDAP stock can currently be purchased for approximately $3.20.

How big of a company is Edap Tms?

Edap Tms has a market capitalization of $92.79 million and generates $40.74 million in revenue each year. The medical equipment provider earns $-760,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. Edap Tms employs 197 workers across the globe.

How can I contact Edap Tms?

Edap Tms' mailing address is Parc d'Activites la Poudrette-Lamartine 4/6 rue du Dauphine, Vaulx-en-Velin I0, 69120. The medical equipment provider can be reached via phone at 33-04-72-15-31-50 or via email at [email protected]


MarketBeat Community Rating for Edap Tms (EDAP)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  183 (Vote Outperform)
Underperform Votes:  164 (Vote Underperform)
Total Votes:  347
MarketBeat's community ratings are surveys of what our community members think about Edap Tms and other stocks. Vote "Outperform" if you believe EDAP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EDAP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.